Efficacy of Gemcitabine for Locally Advanced Pancreatic Cancer: Comparison with 5-Fluorouracil-Based Chemoradiotherapy

Publisher： Karger

E-ISSN： 1421-9794|54|4|302-308

ISSN： 0009-3157

Source： Chemotherapy, Vol.54, Iss.4, 2008-08, pp. : 302-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Full-Dose Gemcitabine Is a More Effective Chemotherapeutic Agent Than 5-Fluorouracil for Concurrent Chemoradiotherapy as First-Line Treatment in Locally Advanced Pancreatic Cancer

By  

Chemotherapy, Vol. 60, Iss. 3, 2015-03 ,pp. : 191-199

Karger

Access to resources Recommend Favorite

5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Advanced Pancreatic Cancer Who Have Progressed on Gemcitabine-Based Therapy

By  

Chemotherapy, Vol. 59, Iss. 4, 2014-01 ,pp. : 273-279

Karger

Access to resources Recommend Favorite

The Dihydrouracil/Uracil Ratios in Plasma and Toxicities of 5-Fluorouracil-Based Adjuvant Chemotherapy in Colorectal Cancer Patients

By  

Chemotherapy, Vol. 53, Iss. 2, 2007-02 ,pp. : 127-131

Karger

Access to resources Recommend Favorite

The Addition of Target Therapy to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Review

By  

Chemotherapy, Vol. 62, Iss. 5, 2017-06 ,pp. : 314-322

Karger

Access to resources Recommend Favorite

Recurrent Thrombophlebitis in a Colon Cancer Patient with C677T Heterozygous Genotype for MTHFR Treated with 5-Fluorouracil-Based Adjuvant Chemotherapy

By  

Chemotherapy, Vol. 50, Iss. 4, 2004-10 ,pp. : 194-195

Karger

Access to resources Recommend Favorite